Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding selectivity to certain enzyme targets, enhancing drug efficacy. Commonly employed in medicinal chemistry for constructing bioactive molecules due to the stability and metabolic resistance provided by the cyclopropyl and fluorophenyl groups. Also utilized in the preparation of analogs for structure-activity relationship (SAR) studies.